As of 2024-12-15, the Intrinsic Value of Vincerx Pharma Inc (VINC) is
-4.03 USD. This VINC valuation is based on the model Peter Lynch Fair Value.
With the current market price of 0.19 USD, the upside of Vincerx Pharma Inc is
-2,208.44%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
-4.03 USD
Intrinsic Value
VINC Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| Fair Value |
-4.03 - -4.03 |
-4.03 |
-2,208.44% |
| P/E |
(16.69) - (15.48) |
(18.04) |
-9545.8% |
| DDM - Stable |
(4.87) - (12.63) |
(8.75) |
-4682.0% |
| DDM - Multi |
(6.45) - (13.26) |
(8.71) |
-4658.5% |
VINC Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
6.41 |
| Beta |
2.25 |
| Outstanding shares (mil) |
33.56 |
| Enterprise Value (mil) |
3.47 |
| Market risk premium |
4.60% |
| Cost of Equity |
12.66% |
| Cost of Debt |
5.00% |
| WACC |
8.16% |